Coinbase Expands Global Reach with Stock Perpetual Futures for Non-US Traders
In a significant move to blur the lines between traditional finance and digital assets, Coinbase has launched stock perpetual futures for eligible non-US traders. This new product, detailed in a Friday blog post, marks a key step in the exchange’s strategy to become a unified, 24/7 marketplace for crypto, equities, and prediction markets. The contracts, available on both Coinbase Advanced for retail users and the Coinbase International Exchange for institutions, offer leveraged, cash-settled exposure to major US stocks like Apple (AAPL) and Nvidia (NVDA), as well as key indices, using a format familiar to crypto traders.
The rollout explicitly excludes US persons, with Coinbase stating it is “working to expand this offering to additional regions in the future.” This geographic restriction aligns with the complex regulatory landscape in the United States surrounding derivatives and securities. The launch follows other Coinbase initiatives, including regulated crypto futures and 24/5 cash equities in the US, and the nationwide introduction of Kalshi-powered prediction markets, all feeding into CEO Brian Armstrong’s vision of a global “everything exchange.”
Strategic International Push and European Rollout
Stock perpetual futures are a cornerstone of Coinbase’s publicly stated 2026 roadmap, which heavily emphasizes stablecoin utility, its Base layer-2 network, and a multi-asset brokerage model. Armstrong identified in January that the top priority is scaling this integrated platform globally across crypto, equities, prediction markets, and commodities across spot, futures, and options.
For European customers, the launch is particularly structured. Earlier in March, Coinbase introduced perpetual futures contracts for Advanced users in 26 European countries under its Markets in Financial Instruments Directive (MiFID) entity. This regulatory framework provides a compliant pathway for offering such derivatives within the European Economic Area, showcasing a phased, region-specific approach to global expansion.
Entering a Competitive and Fragmented Synthetic Equity Market
Coinbase now enters a crowded but disjointed market for synthetic equity exposure. Its primary rivals include Binance, which offers its own suite of equity perpetual contracts; Kraken, which provides tokenized equity perpetual futures for non-US traders; and various offshore platforms that list single-stock and index perps with differing regulatory oversight. This fragmentation means traders’ choices often depend heavily on their jurisdiction and risk tolerance regarding regulatory clarity.
The sector’s growth is underscored by a recent milestone: tokenized stocks surpassed $1 billion in total on-chain value earlier in March. This figure highlights the accelerating trend of bringing real-world assets (RWA) like equities on-chain, a movement that directly facilitates products like Coinbase’s new stock perps. As these markets evolve, the distinction between accessing a traditional stock via a brokerage and gaining leveraged, crypto-style exposure to its price continues to dissolve.
AI Eye: IronClaw Rivals OpenClaw, Olas Launches Bots for Polymarket
In adjacent news within the crypto trading ecosystem, AI agent competition is heating up. The IronClaw platform has emerged as a direct rival to the established OpenClaw service, both focusing on autonomous trading strategies. Separately, the Olas protocol has announced the launch of specialized trading bots designed to operate on the prediction market platform Polymarket, indicating a trend of AI automation spreading across diverse on-chain financial applications.
This article is based on information from Coinbase’s official blog announcements and public market data. Cointelegraph is committed to independent, transparent journalism. This news article is produced in accordance with Cointelegraph’s Editorial Policy and aims to provide accurate and timely information. Readers are encouraged to verify information independently, particularly regarding product availability and regulatory status in their specific jurisdiction.
